ArticleTrials2022

Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial.

Moataz Maher Emara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.